|
Background publications
|
Egler, Burlingame, Nuchtern, Russell: "Interleukin-6 and soluble interleukin-6 receptor levels as markers of disease extent and prognosis in neuroblastoma." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 14, Issue 21, pp. 7028-34, 2008
Egler, Burlingame, Nuchtern, Russell: "Interleukin-6 and soluble interleukin-6 receptor levels as markers of disease extent and prognosis in neuroblastoma." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 14, Issue 21, pp. 7028-34, 2008 (PubMed).
Yoshio-Hoshino, Adachi, Aoki, Pereboev, Curiel, Nishimoto: "Establishment of a new interleukin-6 (IL-6) receptor inhibitor applicable to the gene therapy for IL-6-dependent tumor." in: Cancer research, Vol. 67, Issue 3, pp. 871-5, 2007 (PubMed).
Ancey, Küster, Haan, Herrmann, Heinrich, Müller-Newen: "A fusion protein of the gp130 and interleukin-6Ralpha ligand-binding domains acts as a potent interleukin-6 inhibitor." in: The Journal of biological chemistry, Vol. 278, Issue 19, pp. 16968-72, 2003 (PubMed).
Müller-Newen, Küster, Hemmann, Keul, Horsten, Martens, Graeve, Wijdenes, Heinrich: "Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 161, Issue 11, pp. 6347-55, 1998 (PubMed).
Yamasaki, Taga, Hirata, Yawata, Kawanishi, Seed, Taniguchi, Hirano, Kishimoto: "Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor." in: Science (New York, N.Y.), Vol. 241, Issue 4867, pp. 825-8, 1988 (PubMed).
|